TreeWAS – Variant ID: rs912969

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K80.2 Calculus of gallbladder without cholecystitis	0.000	0.977	0.023
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.017	0.983	0.000
C83.3 Large cell (diffuse)	0.015	0.985	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.014	0.986	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.014	0.986	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.013	0.987	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.013	0.987	0.000
Y40 Systemic antibiotics	0.013	0.987	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.012	0.988	0.000
C83.1 Small cleaved cell (diffuse)	0.012	0.988	0.000
C83.0 Small cell (diffuse)	0.012	0.988	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.012	0.988	0.000
Y46.2 Hydantoin derivatives	0.012	0.988	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.011	0.989	0.000
Y40.0 Penicillins	0.011	0.989	0.000
Y40.9 Systemic antibiotic, unspecified	0.011	0.989	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.011	0.989	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.011	0.989	0.000
Y48 Anaesthetics and therapeutic gases	0.011	0.989	0.000
Y40.3 Macrolides	0.010	0.989	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.010	0.990	0.000
C83.7 Burkitt's tumour	0.010	0.990	0.000
C83.6 Undifferentiated (diffuse)	0.010	0.990	0.000
C83.5 Lymphoblastic (diffuse)	0.010	0.990	0.000
C83.4 Immunoblastic (diffuse)	0.010	0.990	0.000
C83.2 Mixed small and large cell (diffuse)	0.010	0.990	0.000
Y45.8 Other analgesics and antipyretics	0.010	0.990	0.000
Y45.2 Propionic acid derivatives	0.010	0.990	0.000
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.990	0.010
C85.1 B-cell lymphoma, unspecified	0.010	0.990	0.000
Y45.5 4-Aminophenol derivatives	0.010	0.990	0.000
Y40.8 Other systemic antibiotics	0.010	0.990	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.010	0.990	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.010	0.990	0.000
Y45.4 Antirheumatics	0.010	0.990	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.010	0.990	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.010	0.990	0.000
I47.2 Ventricular tachycardia	0.010	0.990	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.010	0.990	0.000
Y43 Primarily systemic agents	0.010	0.990	0.000
Y46.4 Iminostilbenes	0.010	0.990	0.000
Y44 Agents primarily affecting blood constituents	0.010	0.990	0.000
Y59 Other and unspecified vaccines and biological substances	0.009	0.990	0.000
Y58 Bacterial vaccines	0.009	0.990	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.009	0.990	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.009	0.990	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.010	0.990	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.009	0.991	0.000
Y40.7 Antifungal antibiotics, systemically used	0.009	0.991	0.000
Y40.6 Rifamycins	0.009	0.991	0.000
Y40.5 Aminoglycosides	0.009	0.991	0.000
Y40.4 Tetracyclines	0.009	0.991	0.000
Y40.2 Chloramphenicol group	0.009	0.991	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.009	0.991	0.000
Y46.8 Antispasticity drugs	0.009	0.991	0.000
Y46.7 Anti-Parkinsonism drugs	0.009	0.991	0.000
Y46.6 Other and unspecified antiepileptics	0.009	0.991	0.000
Y46.5 Valproic acid	0.009	0.991	0.000
Y46.3 Deoxybarbiturates	0.009	0.991	0.000
Y46.1 Oxazolidinediones	0.009	0.991	0.000
Y46.0 Succinimides	0.009	0.991	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.009	0.991	0.000
Y43.1 Antineoplastic antimetabolites	0.009	0.991	0.000
Y48.2 Other and unspecified general anaesthetics	0.009	0.991	0.000
Y52 Agents primarily affecting the cardiovascular system	0.009	0.991	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.009	0.991	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.009	0.991	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.008	0.991	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.008	0.991	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.008	0.992	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.008	0.992	0.000
C85.0 Lymphosarcoma	0.008	0.992	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.008	0.992	0.000
C82.2 Large cell, follicular	0.008	0.992	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.008	0.992	0.000
Y48.3 Local anaesthetics	0.008	0.992	0.000
Y41.5 Antiviral drugs	0.008	0.992	0.000
C82.0 Small cleaved cell, follicular	0.008	0.992	0.000
Y47.1 Benzodiazepines	0.008	0.992	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.008	0.992	0.000
C95 Leukaemia of unspecified cell type	0.008	0.992	0.000
C94 Other leukaemias of specified cell type	0.008	0.992	0.000
C93 Monocytic leukaemia	0.008	0.992	0.000
C86 Other specified types of T/NK-cell lymphoma	0.008	0.992	0.000
C88 Malignant immunoproliferative diseases	0.008	0.992	0.000
Y43.0 Antiallergic and antiemetic drugs	0.008	0.992	0.000
Y43.4 Immunosuppressive agents	0.008	0.992	0.000
Y48.5 Therapeutic gases	0.008	0.992	0.000
Y48.4 Anaesthetic, unspecified	0.008	0.992	0.000
Y48.1 Parenteral anaesthetics	0.008	0.992	0.000
Y48.0 Inhaled anaesthetics	0.008	0.992	0.000
Y45.0 Opioids and related analgesics	0.008	0.992	0.000
Y57 Other and unspecified drugs and medicaments	0.008	0.992	0.000
Y45.1 Salicylates	0.007	0.992	0.000
C82.6 Cutaneous follicle centre lymphoma	0.007	0.992	0.000
C82.5 Diffuse follicle centre lymphoma	0.007	0.992	0.000
C82.4 Follicular lymphoma grade IIIb	0.007	0.992	0.000
C82.3 Follicular lymphoma grade IIIa	0.007	0.992	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.007	0.992	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.007	0.992	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.007	0.992	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.007	0.992	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.007	0.992	0.000
Y47.4 Bromine compounds	0.007	0.992	0.000
Y47.3 Paraldehyde	0.007	0.992	0.000
Y47.2 Chloral derivatives	0.007	0.992	0.000
Y47.0 Barbiturates, not elsewhere classified	0.007	0.992	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.993	0.000
Y41.4 Anthelminthics	0.007	0.993	0.000
Y41.3 Other antiprotozoal drugs	0.007	0.993	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.007	0.993	0.000
Y41.1 Antimycobacterial drugs	0.007	0.993	0.000
Y41.0 Sulphonamides	0.007	0.993	0.000
Y42.9 Other and unspecified hormone antagonists	0.007	0.993	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.007	0.993	0.000
Y42.4 Oral contraceptives	0.007	0.993	0.000
Y42.2 Antithyroid drugs	0.007	0.993	0.000
Y42.1 Thyroid hormones and substitutes	0.007	0.993	0.000
Y43.9 Primarily systemic agent, unspecified	0.007	0.993	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.007	0.993	0.000
Y43.6 Enzymes, not elsewhere classified	0.007	0.993	0.000
Y43.5 Acidifying and alkalising agents	0.007	0.993	0.000
Y43.2 Antineoplastic natural products	0.007	0.993	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993	0.000
Y44.2 Anticoagulants	0.007	0.993	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.007	0.993	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.007	0.993	0.000
Y44.7 Plasma substitutes	0.007	0.993	0.000
Y44.6 Natural blood and blood products	0.007	0.993	0.000
Y44.5 Thrombolytic drugs	0.007	0.993	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.007	0.993	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.007	0.993	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.007	0.993	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.007	0.993	0.000
Y42.7 Androgens and anabolic congeners	0.007	0.993	0.000
Y50.9 Central nervous system stimulant, unspecified	0.007	0.993	0.000
Y50.8 Other central nervous system stimulants	0.007	0.993	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.007	0.993	0.000
Y50.1 Opioid receptor antagonists	0.007	0.993	0.000
Y50.0 Analeptics	0.007	0.993	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.007	0.993	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.007	0.993	0.000
Y55.5 Anticommon cold drugs	0.007	0.993	0.000
Y55.4 Expectorants	0.007	0.993	0.000
Y55.3 Antitussives	0.007	0.993	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.007	0.993	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.007	0.993	0.000
Y55.0 Oxytocic drugs	0.007	0.993	0.000
Y58.9 Other and unspecified bacterial vaccines	0.007	0.993	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.007	0.993	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.007	0.993	0.000
Y58.5 Diphtheria vaccine	0.007	0.993	0.000
Y58.4 Tetanus vaccine	0.007	0.993	0.000
Y58.3 Plague vaccine	0.007	0.993	0.000
Y58.2 Cholera vaccine	0.007	0.993	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.007	0.993	0.000
Y58.0 BCG vaccine	0.007	0.993	0.000
Y59.9 Vaccine or biological substance, unspecified	0.007	0.993	0.000
Y59.8 Other specified vaccines and biological substances	0.007	0.993	0.000
Y59.3 Immunoglobulin	0.007	0.993	0.000
Y59.2 Protozoal vaccines	0.007	0.993	0.000
Y59.1 Rickettsial vaccines	0.007	0.993	0.000
Y59.0 Viral vaccines	0.007	0.993	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.007	0.993	0.000
C84.4 Peripheral T-cell lymphoma	0.007	0.993	0.000
Y56.9 Topical agent, unspecified	0.007	0.993	0.000
Y56.8 Other topical agents	0.007	0.993	0.000
Y56.7 Dental drugs, topically applied	0.007	0.993	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.007	0.993	0.000
Y56.5 Ophthalmological drugs and preparations	0.007	0.993	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.007	0.993	0.000
Y56.3 Emollients, demulcents and protectants	0.007	0.993	0.000
Y56.2 Local astringents and local detergents	0.007	0.993	0.000
Y56.1 Antipruritics	0.007	0.993	0.000
Y52.1 Calcium-channel blockers	0.007	0.993	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.007	0.993	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.007	0.993	0.000
Y53.7 Emetics	0.007	0.993	0.000
Y53.6 Antidiarrhoeal drugs	0.007	0.993	0.000
Y53.5 Digestants	0.007	0.993	0.000
Y53.4 Other laxatives	0.007	0.993	0.000
Y53.3 Saline and osmotic laxatives	0.007	0.993	0.000
Y53.2 Stimulant laxatives	0.007	0.993	0.000
Y53.0 Histamine H2-receptor antagonists	0.007	0.993	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993	0.000
C91 Lymphoid leukaemia	0.007	0.993	0.000
Y49.9 Psychotropic drug, unspecified	0.007	0.993	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
Y49.7 Psychostimulants with abuse potential	0.007	0.993	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.007	0.993	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.007	0.993	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.007	0.993	0.000
Y49.2 Other and unspecified antidepressants	0.007	0.993	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.007	0.993	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.007	0.993	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.007	0.993	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.006	0.993	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.006	0.993	0.000
Y52.7 Peripheral vasodilators	0.006	0.993	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.006	0.993	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.993	0.000
C84.5 Other and unspecified T-cell lymphomas	0.006	0.993	0.000
Y54.5 Other diuretics	0.006	0.993	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.006	0.993	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.006	0.993	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.006	0.993	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.006	0.993	0.000
C84.3 Lymphoepithelioid lymphoma	0.006	0.993	0.000
C84.2 T-zone lymphoma	0.006	0.993	0.000
C84.1 Sezary's diease	0.006	0.993	0.000
C84.0 Mycosis fungoides	0.006	0.993	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.006	0.993	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.006	0.993	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.006	0.993	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.006	0.993	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.006	0.993	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.006	0.993	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.006	0.993	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.006	0.993	0.000
Y51.0 Anticholinesterase agents	0.006	0.993	0.000
Y49.5 Other antipsychotics and neuroleptics	0.006	0.994	0.000
Y54.9 Mineral salts, not elsewhere classified	0.006	0.994	0.000
Y54.8 Agents affecting uric acid metabolism	0.006	0.994	0.000
Y54.7 Agents affecting calcification	0.006	0.994	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.006	0.994	0.000
Y54.4 Loop [high-ceiling] diuretics	0.006	0.994	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.006	0.994	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.006	0.994	0.000
Y54.0 Mineralocorticoids	0.006	0.994	0.000
I71 Aortic aneurysm and dissection	0.006	0.994	0.000
I71.0 Dissection of aorta [any part]	0.006	0.994	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.006	0.994	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.006	0.994	0.000
C86.4 Blastic NK-cell lymphoma	0.006	0.994	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.006	0.994	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.006	0.994	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.006	0.994	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.006	0.994	0.000
C93.9 Monocytic leukaemia, unspecified	0.006	0.994	0.000
C93.7 Other monocytic leukaemia	0.006	0.994	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.006	0.994	0.000
C93.2 Subacute monocytic leukaemia	0.006	0.994	0.000
C93.1 Chronic monocytic leukaemia	0.006	0.994	0.000
C93.0 Acute monocytic leukaemia	0.006	0.994	0.000
C94.7 Other specified leukaemias	0.006	0.994	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.006	0.994	0.000
C94.5 Acute myelofibrosis	0.006	0.994	0.000
C94.4 Acute panmyelosis	0.006	0.994	0.000
C94.3 Mast cell leukaemia	0.006	0.994	0.000
C94.2 Acute megakaryoblastic leukaemia	0.006	0.994	0.000
C94.1 Chronic erythraemia	0.006	0.994	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.006	0.994	0.000
C95.9 Leukaemia, unspecified	0.006	0.994	0.000
C95.7 Other leukaemia of unspecified cell type	0.006	0.994	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.006	0.994	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.006	0.994	0.000
C95.0 Acute leukaemia of unspecified cell type	0.006	0.994	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.006	0.994	0.000
C96.8 Histiocytic sarcoma	0.006	0.994	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.006	0.994	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.006	0.994	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.006	0.994	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.006	0.994	0.000
C96.3 True histiocytic lymphoma	0.006	0.994	0.000
C96.2 Malignant mast cell tumour	0.006	0.994	0.000
C96.1 Malignant histiocytosis	0.006	0.994	0.000
C96.0 Letterer-Siwe disease	0.006	0.994	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.006	0.994	0.000
C88.7 Other malignant immunoproliferative diseases	0.006	0.994	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.006	0.994	0.000
C88.3 Immunoproliferative small intestinal disease	0.006	0.994	0.000
C88.2 Gamma heavy chain disease	0.006	0.994	0.000
C88.1 Alpha heavy chain disease	0.006	0.994	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.006	0.994	0.000
Y57.7 Vitamins, not elsewhere classified	0.006	0.994	0.000
Y57.6 Other diagnostic agents	0.006	0.994	0.000
Y57.4 Pharmaceutical excipients	0.006	0.994	0.000
Y57.3 Alcohol deterrents	0.006	0.994	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
Y57.1 Lipotropic drugs	0.006	0.994	0.000
Y57.0 Appetite depressants [anorectics]	0.006	0.994	0.000
E05.9 Thyrotoxicosis, unspecified	0.006	0.994	0.000
C81 Hodgkin's disease	0.005	0.994	0.000
Y57.5 X-ray contrast media	0.006	0.994	0.000
C92 Myeloid leukaemia	0.005	0.994	0.000
Y42.5 Other oestrogens and progestogens	0.005	0.994	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.994	0.000
Y57.8 Other drugs and medicaments	0.005	0.994	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.005	0.995	0.000
C90.2 Plasmacytoma, extramedullary	0.005	0.995	0.000
C90.3 Solitary plasmacytoma	0.005	0.995	0.000
C90.1 Plasma cell leukaemia	0.005	0.995	0.000
C91.9 Lymphoid leukaemia, unspecified	0.005	0.995	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.005	0.995	0.000
C91.7 Other lymphoid leukaemia	0.005	0.995	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.005	0.995	0.000
C91.5 Adult T-cell leukaemia	0.005	0.995	0.000
C91.3 Prolymphocytic leukaemia	0.005	0.995	0.000
C91.2 Subacute lymphocytic leukaemia	0.005	0.995	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
C91.1 Chronic lymphocytic leukaemia	0.005	0.995	0.000
Y54.3 Benzothiadiazine derivatives	0.005	0.995	0.000
C91.4 Hairy-cell leukaemia	0.005	0.995	0.000
T93.2 Sequelae of other fractures of lower limb	0.005	0.995	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.005	0.995	0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.005	0.995	0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.005	0.995	0.000
I71.1 Thoracic aortic aneurysm, ruptured	0.005	0.995	0.000
C91.0 Acute lymphoblastic leukaemia	0.005	0.995	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.000	0.995	0.005
E05.0 Thyrotoxicosis with diffuse goitre	0.005	0.995	0.000
R30.0 Dysuria	0.000	0.995	0.005
K35.9 Acute appendicitis, unspecified	0.000	0.995	0.005
I71.3 Abdominal aortic aneurysm, ruptured	0.004	0.995	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.005	0.995	0.000
R60.0 Localised oedema	0.000	0.995	0.005
Y57.9 Drug or medicament, unspecified	0.004	0.995	0.000
C81.7 Other Hodgkin's disease	0.004	0.996	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.004	0.996	0.000
C81.3 Lymphocytic depletion	0.004	0.996	0.000
C81.2 Mixed cellularity	0.004	0.996	0.000
C81.0 Lymphocytic predominance	0.004	0.996	0.000
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract	0.000	0.996	0.004
C90.0 Multiple myeloma	0.004	0.996	0.000
C92.9 Myeloid leukaemia, unspecified	0.004	0.996	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.004	0.996	0.000
C92.7 Other myeloid leukaemia	0.004	0.996	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.004	0.996	0.000
C92.5 Acute myelomonocytic leukaemia	0.004	0.996	0.000
C92.4 Acute promyelocytic leukaemia	0.004	0.996	0.000
C92.3 Myeloid sarcoma	0.004	0.996	0.000
C92.2 Subacute myeloid leukaemia	0.004	0.996	0.000
E53.8 Deficiency of other specified B group vitamins	0.000	0.996	0.004
E05 Thyrotoxicosis [hyperthyroidism]	0.004	0.996	0.000
H25.8 Other senile cataract	0.004	0.996	0.000
W51.9 Unspecified place	0.004	0.996	0.000
C81.1 Nodular sclerosis	0.004	0.996	0.000
T93 Sequelae of injuries of lower limb	0.004	0.996	0.000
I47 Paroxysmal tachycardia	0.004	0.996	0.000
Chapter XX External causes of morbidity and mortality	0.004	0.996	0.000
T93.1 Sequelae of fracture of femur	0.004	0.996	0.000
W51 Striking against or bumped into by another person	0.004	0.996	0.000
W50-W64 Exposure to animate mechanical forces	0.004	0.996	0.000
V40-V49 Car occupant injured in transport accident	0.004	0.996	0.000
C92.1 Chronic myeloid leukaemia	0.003	0.996	0.000
I47.0 Reentry ventricular arrhythmia	0.004	0.996	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.003	0.996	0.000
I47.9 Paroxysmal tachycardia, unspecified	0.003	0.997	0.000
V10-V19 Pedal cyclist injured in transport accident	0.003	0.997	0.000
O16 Unspecified maternal hypertension	0.000	0.997	0.003
Y00-Y09 Assault	0.003	0.997	0.000
X10-X19 Contact with heat and hot substances	0.003	0.997	0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.003	0.997	0.000
K37 Unspecified appendicitis	0.000	0.997	0.003
E05.8 Other thyrotoxicosis	0.003	0.997	0.000
E05.5 Thyroid crisis or storm	0.003	0.997	0.000
E05.4 Thyrotoxicosis factitia	0.003	0.997	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.003	0.997	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.003	0.997	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.003	0.997	0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.003	0.997	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.003	0.997	0.000
V20-V29 Motorcycle rider injured in transport accident	0.003	0.997	0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus	0.003	0.997	0.000
Y35-Y36 Legal intervention and operations of war	0.003	0.997	0.000
Y10-Y34 Event of undetermined intent	0.003	0.997	0.000
X85-X99 Assault	0.003	0.997	0.000
X30-X39 Exposure to forces of nature	0.003	0.997	0.000
X20-X29 Contact with venomous animals and plants	0.003	0.997	0.000
X00-X09 Exposure to smoke, fire and flames	0.003	0.997	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.003	0.997	0.000
W75-W84 Other accidental threats to breathing	0.003	0.997	0.000
W65-W74 Accidental drowning and submersion	0.003	0.997	0.000
V98-V99 Other and unspecified transport accidents	0.003	0.997	0.000
V95-V97 Air and space transport accidents	0.003	0.997	0.000
V90-V94 Water transport accidents	0.003	0.997	0.000
V70-V79 Bus occupant injured in transport accident	0.003	0.997	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.003	0.997	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.003	0.997	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.003	0.997	0.000
V01-V09 Pedestrian injured in transport accident	0.003	0.997	0.000
C92.0 Acute myeloid leukaemia	0.003	0.997	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.003	0.997	0.000
V43 Car occupant injured in collision with car, pick-up truck or van	0.003	0.997	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.003	0.997	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.003	0.997	0.000
V80-V89 Other land transport accidents	0.003	0.997	0.000
C81.9 Hodgkin's disease, unspecified	0.002	0.997	0.001
R12 Heartburn	0.003	0.997	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.003	0.997	0.000
W17 Other fall from one level to another	0.003	0.997	0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.003	0.997	0.000
W51.8 Other specified place	0.003	0.997	0.000
W51.3 Sports and athletics area	0.003	0.997	0.000
W51.0 Home	0.003	0.997	0.000
W51.7 Farm	0.003	0.997	0.000
W51.6 Industrial and construction area	0.003	0.997	0.000
W51.5 Trade and service area	0.003	0.997	0.000
W51.4 Street and highway	0.003	0.997	0.000
W51.2 School, other institution and public administrative area	0.003	0.997	0.000
W51.1 Residential institution	0.003	0.997	0.000
V18.3 Person injured while boarding or alighting	0.003	0.997	0.000
Y04 Assault by bodily force	0.003	0.997	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.003	0.997	0.000
W64 Exposure to other and unspecified animate mechanical forces	0.003	0.997	0.000
W60 Contact with plant thorns and spines and sharp leaves	0.003	0.997	0.000
W59 Bitten or crushed by other reptiles	0.003	0.997	0.000
W58 Bitten or struck by crocodile or alligator	0.003	0.997	0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.003	0.997	0.000
W56 Contact with marine animal	0.003	0.997	0.000
W54 Bitten or struck by dog	0.003	0.997	0.000
W53 Bitten by rat	0.003	0.997	0.000
W52 Crushed, pushed and stepped on by crowd or human stampede	0.003	0.997	0.000
X50-X57 Overexertion, travel and privation	0.003	0.997	0.000
W00-W19 Falls	0.003	0.997	0.000
V48 Car occupant injured in noncollision transport accident	0.003	0.997	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.003	0.997	0.000
V19 Pedal cyclist injured in other and unspecified transport accidents	0.003	0.997	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.003	0.997	0.000
V47 Car occupant injured in collision with fixed or stationary object	0.003	0.997	0.000
V46 Car occupant injured in collision with other nonmotor vehicle	0.003	0.997	0.000
V45 Car occupant injured in collision with railway train or railway vehicle	0.003	0.997	0.000
V42 Car occupant injured in collision with two- or three-wheeled motor vehicle	0.003	0.997	0.000
V41 Car occupant injured in collision with pedal cycle	0.003	0.997	0.000
V40 Car occupant injured in collision with pedestrian or animal	0.003	0.997	0.000
X12 Contact with other hot fluids	0.003	0.997	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.003	0.997	0.000
Z98.1 Arthrodesis status	0.000	0.997	0.003
T90.5 Sequelae of intracranial injury	0.003	0.997	0.000
T93.0 Sequelae of open wound of lower limb	0.003	0.997	0.000
W17.5 Trade and service area	0.003	0.997	0.000
I67.8 Other specified cerebrovascular diseases	0.003	0.997	0.000
W17.4 Street and highway	0.003	0.997	0.000
V17 Pedal cyclist injured in collision with fixed or stationary object	0.003	0.997	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.003	0.997	0.000
S52.60 Fracture of lower end of both ulna and radius (closed)	0.000	0.997	0.003
V16 Pedal cyclist injured in collision with other nonmotor vehicle	0.003	0.997	0.000
V15 Pedal cyclist injured in collision with railway train or railway vehicle	0.003	0.997	0.000
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus	0.003	0.997	0.000
V13 Pedal cyclist injured in collision with car, pick-up truck or van	0.003	0.997	0.000
V12 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle	0.003	0.997	0.000
V11 Pedal cyclist injured in collision with other pedal cycle	0.003	0.997	0.000
V10 Pedal cyclist injured in collision with pedestrian or animal	0.003	0.997	0.000
T90 Sequelae of injuries of head	0.003	0.997	0.000
W55 Bitten or struck by other mammals	0.003	0.997	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.003	0.997	0.000
Y04.8 Other specified place	0.003	0.997	0.000
Y09 Assault by unspecified means	0.002	0.997	0.000
Y08 Assault by other specified means	0.002	0.997	0.000
Y07 Other maltreatment syndromes	0.002	0.997	0.000
Y06 Neglect and abandonment	0.002	0.997	0.000
Y05 Sexual assault by bodily force	0.002	0.997	0.000
Y03 Assault by crashing of motor vehicle	0.002	0.997	0.000
Y02 Assault by pushing or placing victim before moving object	0.002	0.997	0.000
Y01 Assault by pushing from high place	0.002	0.997	0.000
Y00 Assault by blunt object	0.002	0.997	0.000
Z13 Special screening examination for other diseases and disorders	0.000	0.997	0.003
V44.5 Driver injured in traffic accident	0.002	0.997	0.000
X19 Contact with other and unspecified heat and hot substances	0.002	0.997	0.000
X18 Contact with other hot metals	0.002	0.997	0.000
X17 Contact with hot engines, machinery and tools	0.002	0.997	0.000
X16 Contact with hot heating appliances, radiators and pipes	0.002	0.997	0.000
X15 Contact with hot household appliances	0.002	0.997	0.000
X14 Contact with hot air and gases	0.002	0.997	0.000
X13 Contact with steam and hot vapours	0.002	0.997	0.000
X11 Contact with hot tap-water	0.002	0.997	0.000
X10 Contact with hot drinks, food, fats and cooking oils	0.002	0.997	0.000
V43.9 Unspecified car occupant injured in traffic accident	0.002	0.997	0.000
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.997	0.000
X12.0 Home	0.002	0.997	0.000
V49.8 Car occupant [any] injured in other specified transport accidents	0.002	0.997	0.000
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.997	0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.997	0.000
V49.3 Car occupant [any] injured in unspecified nontraffic accident	0.002	0.997	0.000
V49.2 Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.997	0.000
V49.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.997	0.000
V49.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.997	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.002	0.997	0.000
T95 Sequelae of burns, corrosions and frostbite	0.003	0.997	0.000
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.003	0.997	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.003	0.997	0.000
V23 Motorcycle rider injured in collision with car, pick-up truck or van	0.002	0.997	0.000
S72.40 Fracture of lower end of femur (closed)	0.003	0.997	0.000
I49.5 Sick sinus syndrome	0.000	0.997	0.003
I49.3 Ventricular premature depolarisation	0.000	0.997	0.003
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident	0.002	0.997	0.000
V29 Motorcycle rider injured in other and unspecified transport accidents	0.002	0.997	0.000
V28 Motorcycle rider injured in noncollision transport accident	0.002	0.997	0.000
V27 Motorcycle rider injured in collision with fixed or stationary object	0.002	0.997	0.000
V26 Motorcycle rider injured in collision with other nonmotor vehicle	0.002	0.997	0.000
V25 Motorcycle rider injured in collision with railway train or railway vehicle	0.002	0.997	0.000
V24 Motorcycle rider injured in collision with heavy transport vehicle or bus	0.002	0.997	0.000
V22 Motorcycle rider injured in collision with two- or three-wheeled motor vehicle	0.002	0.997	0.000
V21 Motorcycle rider injured in collision with pedal cycle	0.002	0.997	0.000
V20 Motorcycle rider injured in collision with pedestrian or animal	0.002	0.997	0.000
F81.9 Developmental disorder of scholastic skills, unspecified	0.002	0.997	0.000
T91 Sequelae of injuries of neck and trunk	0.002	0.997	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.002	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations